Bend Delves Into Biotherapeutics | Chemical & Engineering News
Volume 90 Issue 13 | p. 27 | Concentrates
Issue Date: March 26, 2012

Bend Delves Into Biotherapeutics

Department: Business
Keywords: formulation, biopharmaceuticals, custom manufacturing
[+]Enlarge
A bioreactor at Bend’s Oregon labs.
Credit: Bend Research
A photo of a Bend Research Lab.
 
A bioreactor at Bend’s Oregon labs.
Credit: Bend Research

Bend Research, an Oregon-based drug formulation development firm, is expanding its process engineering capabilities into biotherapeutics production. As part of a long-term collaboration, Bend and Pfizer have been developing bioprocessing tools and models, along with process analytics, to advance Pfizer’s biopharmaceutical and vaccine candidates. The partners are also designing a “plant of the future” that reduces capital investment by one-half and operating costs by two-thirds.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment